Emtricitabine + Tenofovir Disoproxil Fumarate fixed-dose combination as Oral Pre-Exposure Prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-infection

GOVPH

Date of publication: 16 December 2021 (for appeals until 30 December 2021)

Evidence Summary: https://bit.ly/PrelimES-OralPrEP-Dec21

Advisory for Appeals on Preliminary Recommendation: https://bit.ly/Advisory-OralPrEP-Recomm

HTAC Recommendation Review:

ES_Oral-PrEP-for-HIV_as-of-Nov-2021_HTAC-Recommendation

Philippine Society of Microbiology and Infectious Diseases (PSMID) releases Philippine COVID-19 Living Recommendations